U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
108991108991Prophylaxis of Hepatitis B Virus Recurrence After Liver TransplantationRecruitingNo Results AvailableLiver Transplantation|Hepatitis BDrug: lamivudine adefovir entecavir HBIGhttps://ClinicalTrials.gov/show/NCT01139203
108992108992Clinical Trial Evaluating Gastrointestinal Damage Following Administration PL3100 or Naproxen in At-Risk AdultsCompletedNo Results AvailableGastroduodenal Ulcerations|ErosionDrug: PL3100|Drug: Naproxenhttps://ClinicalTrials.gov/show/NCT01139190
108993108993SAMBA EU Femoropopliteal TrialActive, not recruitingNo Results AvailablePeripheral Vascular DiseaseDevice: Stenting of atherosclerotic lesion(s)https://ClinicalTrials.gov/show/NCT01139177
108994108994Allogeneic Hematopoietic Stem Cell Transplantation With Reduced Intensity Pre-transplant Conditioning for the Treatment of High-risk Hematological Malignancies (V3)RecruitingNo Results AvailableHematological MalignanciesDrug: Regimen A|Drug: Regimen B|Drug: Regimen Chttps://ClinicalTrials.gov/show/NCT01139164
1089951089954'-Thio-araC (Thiarabine) in Advanced Hematologic MalignanciesCompletedNo Results AvailableLeukemiaDrug: 3 Day Thiarabine|Drug: 5 Day Thiarabinehttps://ClinicalTrials.gov/show/NCT01139151
108996108996Safety Study of the Combination of Panitumumab, Irinotecan and Everolimus in the Treatment of Advanced Colorectal CancerRecruitingNo Results AvailableColorectal Cancer|Colorectal Carcinoma|Colorectal Tumors|Neoplasms, ColorectalDrug: Panitumumab|Drug: Irinotecan|Drug: Everolimushttps://ClinicalTrials.gov/show/NCT01139138
108997108997An Open Trial of Cysteamine Treatment in SchizophreniaTerminatedHas ResultsSchizophrenia|SchizoaffectiveDrug: (Cystagon) Cysteamine Bitartratehttps://ClinicalTrials.gov/show/NCT01139125
108998108998Klebsiella Pneumoniae Necrotizing Fasciitis: Clinical and Microbiological FeaturesCompletedNo Results AvailableNecrotizing Fasciitishttps://ClinicalTrials.gov/show/NCT01139112
108999108999The Evaluation of Therapeutic Efficacy on the Integrated Group Psychotherapy for Patients With SchizophreniaCompletedNo Results AvailableSchizophreniaBehavioral: Group Psychotherapyhttps://ClinicalTrials.gov/show/NCT01139099
109000109000Role of Endothelial Function, Muscular Fitness and Metabolism in Functional Activity in Patients With Chronic Heart Failure (CHF)RecruitingNo Results AvailableChronic Heart Failure|Coronary Disease|Dilated Cardiomyopathyhttps://ClinicalTrials.gov/show/NCT01139086
109001109001A New Portable Monitor for Measuring Odorous Compounds in Oral, Exhaled and Nasal AirCompletedNo Results AvailableHalitosishttps://ClinicalTrials.gov/show/NCT01139073
109002109002Organized Self-Management Support Services for Chronic DepressionCompletedNo Results AvailableDepressionBehavioral: organized care program for chronic or recurrent depressionhttps://ClinicalTrials.gov/show/NCT01139060
109003109003Split-face Tolerability Comparison Between MetroGel® 1% vs Finacea® 15% in Subjects With Healthy SkinCompletedHas ResultsSkin ManifestationsDrug: metronidazole 1% gel|Drug: azelaic acid 15% gelhttps://ClinicalTrials.gov/show/NCT01139047
109004109004A Pilot Study of Shoulder Subluxation Treatment by Using the Self-Designed Surface Functional Electrical StimulatorRecruitingNo Results AvailableStrokeDevice: Self-designed surface functional electrical stimulatorhttps://ClinicalTrials.gov/show/NCT01139034
109005109005One Year Antibody Persistence After a Fourth Dose Boost or Two Catch-Up Doses of Novartis Meningococcal B Recombinant Vaccine Administered Starting From 12 Months of Age and Response to a Third Dose Boost or Two Catch-Up Doses Starting at 24 Months of AgeCompletedHas ResultsMeningococcal DiseaseBiological: rMenB+OMV NZhttps://ClinicalTrials.gov/show/NCT01139021
109006109006Split-Face Tolerability Comparison Between MetroGel® 1% Versus Finacea® 15% in Subjects With Healthy SkinCompletedHas ResultsSkin ManifestationsDrug: metronidazole 1% gel|Drug: azelaic acid 15% gelhttps://ClinicalTrials.gov/show/NCT01139008
109007109007Clinical Study of the L300 Versus Ankle-foot Orthosis (AFO) on Post-Stroke Subjects With Foot DropCompletedNo Results AvailableSensorimotor Gait Disorder|Neurologic Ambulation Disorder|Gait, Drop Foot|Poststroke/CVA HemiparesisDevice: Ness L300|Device: Ness L300https://ClinicalTrials.gov/show/NCT01138995
109008109008Effectiveness Study of a Swedish Youth Mentoring ProgramCompletedNo Results AvailableAdolescenceBehavioral: Youth Mentoring programhttps://ClinicalTrials.gov/show/NCT01138982
109009109009Efficacy of Proton Pump Inhibitor in Prevention of Clopidogrel-related Peptic UlcerCompletedHas ResultsPeptic UlcerDrug: esomeprazolehttps://ClinicalTrials.gov/show/NCT01138969
109010109010Immune Response of Visceral Leishmaniasis PatientsTreated With Antimonial Plus N-AcetylcysteineRecruitingNo Results AvailableVisceral Leishmaniasis|Immune Response|TreatmentDrug: N-acetylcysteine|Drug: Pentavalent antimonialhttps://ClinicalTrials.gov/show/NCT01138956
109011109011Chlorhexidine Mouthrinses and Plaque ControlCompletedNo Results AvailableDental PlaqueDrug: Synthodont|Drug: Soludenthttps://ClinicalTrials.gov/show/NCT01138943
109012109012Effect of Berberine on Hormonal and Metabolic Features in Obese Women With Polycystic Ovary Syndrome (PCOS)RecruitingNo Results AvailablePolycystic Ovary Syndrome|ObesityDrug: Berberine|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01138930
109013109013[Trial of device that is not approved or cleared by the U.S. FDA]WithheldNo Results Availablehttps://ClinicalTrials.gov/show/NCT01138917
109014109014FOLFOX Followed by FOLFIRI or Reverse Sequence Treatment in Advanced Gastric Cancer (AGC)CompletedNo Results AvailableGastric CancerDrug: irinotecan, oxaliplatin|Drug: oxaliplatin, irinotecanhttps://ClinicalTrials.gov/show/NCT01138904
109015109015Sonication of Explanted Breast Implants for Detection of Subclinical InfectionCompletedNo Results AvailableImplants, Breasthttps://ClinicalTrials.gov/show/NCT01138891
109016109016HIV Testing in Non-traditional Settings StudyCompletedNo Results AvailableHIVOther: Questionnaire|Other: Focus Group Discussion|Other: HIV test (serum or salivary)|Other: Semi-structured telephone interviewhttps://ClinicalTrials.gov/show/NCT01138878
109017109017Effect of CPAP on Biomarkers in Patients With OSARecruitingNo Results AvailableObstructive Sleep ApneaDevice: AutoSet Spirit--Wash--Modified-AutoSet Spirit|Device: Modified-AutoSet Spirit--Wash-AutoSet Spirithttps://ClinicalTrials.gov/show/NCT01138865
109018109018Ampicillin/Sulbactam Versus Cefuroxime as Antimicrobial Prophylaxis for Cesarean SectionCompletedNo Results AvailableSurgical Site InfectionsDrug: Ampicillin-sulbactam|Drug: Cefuroximehttps://ClinicalTrials.gov/show/NCT01138852
109019109019Dexamethasone Efficacy in HELLP I SyndromeRecruitingNo Results AvailableHELLP SyndromeDrug: Dexamethasone|Drug: sterile waterhttps://ClinicalTrials.gov/show/NCT01138839
109020109020Bioavailability Study Comparing 10 Mg Amlodipine Besylate Orally Disintegrating Tablet (ODT) And 10 Mg Amlodipine Besylate TabletsCompletedHas ResultsHealthy VolunteersDrug: Amlodipine - reference|Drug: Amlodipine ODT - test|Drug: Amlodipine ODT - testhttps://ClinicalTrials.gov/show/NCT01138826

* Görseller ve İçerik tekif hakkına sahip olabilir